INAB logo

IN8bio (INAB) EBITDA

Annual EBITDA

-$27.84 M
-$418.00 K-1.52%

December 31, 2023


Summary


Performance

INAB EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherINABprofitabilitymetrics:

Quarterly EBITDA

-$5.35 M
+$2.71 M+33.59%

September 30, 2024


Summary


Performance

INAB Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherINABprofitabilitymetrics:

TTM EBITDA

-$28.72 M
+$1.17 M+3.92%

September 30, 2024


Summary


Performance

INAB TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherINABprofitabilitymetrics:

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

INAB EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-1.5%0.0%0.0%
3 y3 years-228.7%0.0%0.0%
5 y5 years-1312.3%0.0%0.0%

INAB EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-100.8%at lowat high+33.6%-107.2%+3.9%
5 y5-year-460.1%at low-222.5%+33.6%-1621.0%+3.9%
alltimeall time-1312.3%at low-222.5%+33.6%-1621.0%+3.9%

IN8bio EBITDA History

DateAnnualQuarterlyTTM
Sep 2024
-
-$5.35 M(-33.6%)
-$28.72 M(-3.9%)
Jun 2024
-
-$8.06 M(+0.6%)
-$29.89 M(+3.4%)
Mar 2024
-
-$8.01 M(+9.8%)
-$28.91 M(+3.9%)
Dec 2023
-$27.84 M(+1.5%)
-$7.30 M(+11.9%)
-$27.84 M(-0.5%)
Sep 2023
-
-$6.52 M(-7.9%)
-$27.98 M(-2.2%)
Jun 2023
-
-$7.08 M(+2.1%)
-$28.61 M(+0.6%)
Mar 2023
-
-$6.93 M(-6.9%)
-$28.44 M(+3.7%)
Dec 2022
-$27.42 M
-$7.45 M(+4.1%)
-$27.42 M(+7.2%)
Sep 2022
-
-$7.15 M(+3.6%)
-$25.59 M(+18.3%)
Jun 2022
-
-$6.91 M(+16.8%)
-$21.63 M(+23.0%)
DateAnnualQuarterlyTTM
Mar 2022
-
-$5.91 M(+5.3%)
-$17.58 M(+26.8%)
Dec 2021
-$13.87 M(+63.7%)
-$5.62 M(+75.9%)
-$13.87 M(+31.6%)
Sep 2021
-
-$3.19 M(+11.6%)
-$10.54 M(+17.0%)
Jun 2021
-
-$2.86 M(+30.1%)
-$9.01 M(+0.1%)
Mar 2021
-
-$2.20 M(-4.0%)
-$9.00 M(+6.2%)
Dec 2020
-$8.47 M(+70.4%)
-$2.29 M(+38.0%)
-$8.47 M(+37.0%)
Sep 2020
-
-$1.66 M(-41.8%)
-$6.18 M(+36.7%)
Jun 2020
-
-$2.85 M(+70.9%)
-$4.52 M(+170.9%)
Mar 2020
-
-$1.67 M
-$1.67 M
Dec 2019
-$4.97 M(+152.2%)
-
-
Dec 2018
-$1.97 M
-
-

FAQ

  • What is IN8bio annual EBITDA?
  • What is the all time high annual EBITDA for IN8bio?
  • What is IN8bio annual EBITDA year-on-year change?
  • What is IN8bio quarterly EBITDA?
  • What is the all time high quarterly EBITDA for IN8bio?
  • What is IN8bio quarterly EBITDA year-on-year change?
  • What is IN8bio TTM EBITDA?
  • What is the all time high TTM EBITDA for IN8bio?
  • What is IN8bio TTM EBITDA year-on-year change?

What is IN8bio annual EBITDA?

The current annual EBITDA of INAB is -$27.84 M

What is the all time high annual EBITDA for IN8bio?

IN8bio all-time high annual EBITDA is -$1.97 M

What is IN8bio annual EBITDA year-on-year change?

Over the past year, INAB annual EBITDA has changed by -$418.00 K (-1.52%)

What is IN8bio quarterly EBITDA?

The current quarterly EBITDA of INAB is -$5.35 M

What is the all time high quarterly EBITDA for IN8bio?

IN8bio all-time high quarterly EBITDA is -$1.66 M

What is IN8bio quarterly EBITDA year-on-year change?

Over the past year, INAB quarterly EBITDA has changed by $0.00 (0.00%)

What is IN8bio TTM EBITDA?

The current TTM EBITDA of INAB is -$28.72 M

What is the all time high TTM EBITDA for IN8bio?

IN8bio all-time high TTM EBITDA is -$1.67 M

What is IN8bio TTM EBITDA year-on-year change?

Over the past year, INAB TTM EBITDA has changed by $0.00 (0.00%)